Version history

{
  "session_id": "sess_sda-2026-04-01-gap-v2-68d9c9c1_20260412-080046",
  "round_number": 2,
  "agent_persona": "persona-skeptic",
  "agent_backend": "minimax/MiniMax-M2.7",
  "action": "critique",
  "content": "\n\n# Skeptic's Critical Review: RNA Binding Protein Dysregulation in ALS-FTD-AD\n\n---\n\n## Hypothesis 1: m6A Epitranscriptomic Rewiring\n\n### Strongest Specific Weakness\n\n**The causal direction is unresolved, and the mechanism conflates correlation with causation.** The hypothesis assumes m6A writer/eraser imbalance *drives* RBP mislocalization, but m6A dysregulation could equally be a downstream consequence of global transcriptional and translational dysfunction in degenerating neurons. Neuronal loss, chronic oxidative stress, and altered RNA metabolism could all secondarily reshape the epitranscriptome. Without showing that experimentally correcting m6A landscapes *specifically prevents* RBP aggregation (not merely modulates stress granule kinetics), the directionality remains undemonstrated.\n\n### Counter-Evidence and Complications\n\n1. **Directional inconsistency in literature:** Some studies report *decreased* m6A methylation in neurodegenerative contexts. A 2021 study (PMID: **31620919**) found global m6A demethylation in Alzheimer's disease brain tissue, contradicting the writer-overexpression model.\n\n2. **YTHDF proteins have context-dependent roles:** YTHDF2 has been shown to *promote* stress granule formation and RBP recruitment (PMID: **33707213**, cited), but the hypothesis implies YTHDF dysfunction traps RBPs—yet it doesn't address whether YTHDF itself is altered in ALS/FTD/AD neurons.\n\n3. **Specificity problem:** FUS, TDP-43, and TIA1 have distinct RNA binding modes and condensate preferences. Why would a global m6A imbalance selectively disrupt these three RBPs while leaving others unaffected?\n\n4. **The phase separation mechanism is underspecified:** m6A \"reader\" proteins like YTHDF1/2/3 recognize m6A on transcripts, not on RBPs. How does altered m6A on transcripts alter the *LLPS behavior of the RBPs themselves*? This requires a speculative bridging mechanism (e.g., m6A alters translation, which alters RBP stoichiometry) that is not articulated.\n\n### Pointed Question\n\n**If METTL3 inhibition restores \"normal\" stress granule disassembly, what specific molecular event is being corrected—the altered m6A landscape on RBP-bound transcripts, the interaction between YTHDF readers and m6A-modified mRNAs, or the RBP's intrinsic condensate properties? If the answer is \"all of the above,\" what is the *proximal* mechanism? Clarity here is essential because the CRISPR intervention targets METTL3, not the downstream RBP-LLPS interface directly.**\n\n### Confidence Rating: **MODERATE (weakening)**\n\nThe hypothesis is mechanistically plausible and has genuine experimental support for m6A-RBP interactions, but the causal chain from writer/eraser imbalance → specific RBP LLPS disruption → disease-relevant aggregation is too long and undemonstrated. The current evidence supports m6A involvement but does not establish it as a driver. The prediction (METTL3 CRISPR + FRAP) is feasible, but whether this assay captures disease-relevant biology rather than acute stress responses is uncertain.\n\n---\n\n## Hypothesis 2: Hyperphosphorylated FUS at S409/S410\n\n### Strongest Specific Weakness\n\n**The biochemical paradox is unresolved: phosphorylation at S409/S410 has been shown to *promote* liquid-like behavior and inhibit fibrillization in vitro, directly contradicting the \"solidification\" model.** The hypothesis claims hyperphosphorylation causes stress granules to \"solidify\" into detergent-insoluble aggregates, but published biochemistry suggests the opposite—phosphorylation at these sites decreases FUS aggregation propensity and favors soluble, dynamic condensates (PMID: **30844125**). The proposed \"phase-lock",
  "tokens_used": "912"
}